Journals / Journal of the Turkish-German Gynecological Association / 2008 / Cilt: 9 - Sayı: 3

Rekürrensli bir lenf nodu metastazlı over kanseri olgusunda konvasiyonel metodlarla lezyon görülemediği durumlarda PET/BT kullanımının önemi

The Importance of using PET/CT investigation in case of recurrence in an ovarian cancer case with lymph node metastasis without any lesions that can be scanned via conventional methods

Pages
172–175
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case, the importance of combined positron emission tomography and computed tomography investigation in patients with suspected recurrence in whom no tumor detectable via conventional methods has been identified was highlighted.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Although lymph node involvement is common in ovarian cancer, axillary and supraclavicular lymph node involvement is quite rare.
📊
Key Findings & Data:In the 55-year-old patient without any lesions that are scannable via conventional methods, in which increase of CA-125 level was detected during follow-up, recurrence was detected via combined positron emission tomography and computed tomography investigation.
💡
Conclusion & Impact:In this case, the importance of combined positron emission tomography and computed tomography investigation in patients with suspected recurrence in whom no tumor detectable via conventional methods has been identified was highlighted.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Although lymph node involvement is common in ovarian cancer, axillary and supraclavicular lymph node involvement is quite rare. In the 55-year-old patient without any lesions that are scannable via conventional methods, in which increase of CA-125 level was detected during follow-up, recurrence was detected via combined positron emission tomography and computed tomography investigation. This case recurring with intraabdominal and supraclavicular and axillary lymph node (which are rare regions of involvement) metastasis has been discussed with literature information. In this case, the importance of combined positron emission tomography and computed tomography investigation in patients with suspected recurrence in whom no tumor detectable via conventional methods has been identified was highlighted.

Özet

Over kanserlerinde lenf nodu tutulumu sık olmakla birlikte, aksiller ve supraklavikular lenf nodu tutulumu nadirdir. Takibi sırasında Ca-125 seviyesinde artış tespit edildiği halde konvansiyonel metodlarla herhangi bir lezyon tespit edilemeyen 55 yaşındaki over kanserli hastada rekürrens pozitron emisyon tomografisi ve bilgisayarlı tomografinin birlikte kullanımı ile tespit edildi. Ender tutulum gösteren suprklavikular ve aksiller lenf nodu ve intraabdominal lenf nodu tutulumu ile rekürrens saptanan hasta literatür ışığında tartışıldı. Bu olguda konvansiyonel metodlarla herhangi bir tümör saptanmayan durumlarda pozitron emisyon tomografisi ve bilgisayarlı tomografinin birlikte kullanımının öneminin altı çizildi.

🔖

Cite This Article

TANRIVERDİ, Ö., UZUNOĞLU, S., ALTANER, Ş., KARAGÖL, H., CİCİN, İ., ALAS, C. R., TOKATLI, F. (2022). Rekürrensli bir lenf nodu metastazlı over kanseri olgusunda konvasiyonel metodlarla lezyon görülemediği durumlarda PET/BT kullanımının önemi. Journal of the Turkish-German Gynecological Association, Cilt: 9 - Sayı: 3, 172–175. https://ajindex.com/articles/567868

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Orris BG, Geisler JP, Geisler HE. Ovarian carcinoma metastatic to bilateral axillary lymph nodes: A case report. Eur J Gynaecol Oncol 1999;20:189-90
  2. Euscher ED, Silva EG, Deavers MT et al. Seous carcinoma of the ovary, fallopian tube, or peritoneum presenting as lymphadenopathy. Am J Surg Pathol 2004;28:1217-23
  3. Fanti S, Nanni C, Castelluci P et al. Supraclavicular lymph node metastatic spread in patients with ovarian cancer disclosed at 18FFDG- PET/CT: an unusual finding. Cancer Imaging 2006;6:20-3
  4. Gontier E, Wortski M, Guinebretiere JM, Alberini JL. 18F-FDGPET/ CT in a patient with lymp node metastasis from ovarian adenocarcinoma. AJR 2006;187:285-9
  5. Thrall MM, Deloia JA, Gallion H, Avril N. Clinical use of combined positron emission tomography and compoted tomography (FDGPET/ CT) in recurrent overian cancer. Gynecol Oncol 2007;105:17-22
  6. Blanchard P, Plantade A, Pages C et al. Isolated lymph node relapse of epithelial ovarian carcinoma: Outcames and prognostic factors. Gynecol Oncol 2007;104:41-5
  7. Mahdavi A, Malviya VK, Husain M. Metastatic inguinal lymphadenopathy, presenting as the only physical evidence of recurrent ovarian carcinoma. J Gynecol Surg 2003;19:81-3
  8. Dvoretsky PM, Richards KA, Angel K et al. Distrubition of disease at autopsy in 100 women with ovarian cancer. Hum Pathol 1988;19:57- 63
  9. Hockstein S, Keh P, Lurain JR, Fishman DA. Ovarian carcinoma initially presenting as metabolic axillary lymphadenopathy. Gynecol Oncol 1997;65:543-7
  10. Bristow RE, del Carmen MG, Pannu HK et al. Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol 2003;90:519-28
  11. Recine MA, Deavers MT, Middleton LP et al. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a pptential pitfall. Am j Surg Pathol 2004;28:1646-51.